Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
GRANULES Stock Analysis
Views
Red Flags
Positive
Strong price momentum
Analysts have been raising forward EPS estimates
High and stable operating margin
Strong EPS growth and above median growth of industry
Low Debt to Equity, not much change from last year
Company's earnings are of high quality
Consistently pays dividend
Negative
Expensive and at same valuation levels as industry median P/E
Low revenue growth and in line with median growth of industry
Low dividend yield
Neutral
Moderate and stable ROE
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
GRANULES Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
GRANULES Bulk, Block & Insider Trades
GRANULES Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Stock split
Others
Stock split(1 : 10)Nominal value change from INR 10 to INR 1. Ex-date: 23rd Mar 2015 Announced on: 28th Jan 2015
Share Buyback"On market Tender offer." Ex-date: 22nd Aug 2022 Announced on: 9th Aug 2022
Share Buyback"On Market Tender Offer." Ex-date: 19th Mar 2020 Announced on: 21st Jan 2020
Company Profile
Granules India Limited is an India-based pharmaceutical manufacturing company. The Company operates through its pharmaceutical products segment. Its geographical segments include within India and outside India. The Company has a presence across the pharmaceutical manufacturing value chain, including... Read More
Key personnel
Dr. Krishna Prasad ChigurupatiD
Executive Chairman of the Board, Managing Director
Mr. Mukesh Surana
Chief Financial Officer
Dr. Rajesh Kapoor
President and Global Head - Quality
Mr. Sanjay Kumar
President and Chief Strategy & Sustainability Officer
Dr. Baskaran P. N.
President & Head - API Operations
Dr. Ramraj Rangarajulu
President and Head - Formulations Operations
Mr. Atul Dhavle
Chief Human Resources Officer
Mr. Manikandan Ramalingam
Senior Vice President & Head Formulation R&D
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Granules India Ltd.?
The current share price of Granules India Ltd. is ₹ 602.13 as of 09 Jan 2026.
What is the PE ratio of Granules India Ltd.?
The Price-to-Earnings (PE) ratio of Granules India Ltd. is 28.49 as of the latest financial data.
What is the ROE and ROCE of Granules India Ltd.?
Granules India Ltd. has a Return on Equity (ROE) of 13.84% and a Return on Capital Employed (ROCE) of 14.52% as per the latest financial reports.
What is the market cap of Granules India Ltd.?
The market capitalization of Granules India Ltd. stands at ₹ 14,611.80 Cr.
What is the dividend yield of Granules India Ltd.?
The dividend yield of Granules India Ltd. is 0.25% based on the current market price.
What is the RSI of Granules India Ltd.?
The Relative Strength Index (RSI) of Granules India Ltd. is 55.37.
What is the FII and DII holding in Granules India Ltd.?
Foreign Institutional Investors (FII) hold 14.09% and Domestic Institutional Investors (DII) hold 17.13% of Granules India Ltd. shares.
What sector does Granules India Ltd. belong to?
Granules India Ltd. operates in the Healthcare sector.
What is the beta of Granules India Ltd. stock?
The beta of Granules India Ltd. stock is 1.48, indicating its volatility relative to the broader market.
